Citi: CSL Injectafer black box label warning likely limited impact
Citi says the FDA-approved revised Injectafer labeling—adding a black box warning about low blood phosphate risk—is unlikely to change much for CSL.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.